benzonatate

Product NDC: 69336-126
11-digit product format: 693360126
Labeler code: 69336
Product ID: 69336-126_dd1e827f-580e-2167-e053-2995a90a5323
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: benzonatate
Dosage form: CAPSULE
Route: ORAL
Labeler: Sterling-Knight Pharmaceuticals, LLC
Application: ANDA040627
Marketing category: ANDA
Marketing start: 2019-03-13
Marketing end: 2022-04-25
Substance: BENZONATATE
Active strength: 150 mg/1
Pharmacologic classes: Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69336-126-15	2022-04-20	C162847	48780-1	ba0f9c33-3f5d-a910-e053-dadaa90a0b85	f582c423-53f1-4a01-a753-0936e3458f3a
69336-126-15	2021-01-29	C162847	48780-1	ba0f9c33-3f5d-a910-e053-dadaa90a0b85	f582c423-53f1-4a01-a753-0936e3458f3a

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69336-126-15	EA - Each	69336-126	6777d7f7-e4e7-431d-b47d-c24f22089769	1	2019-05-02

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5P4DHS6ENR	BENZONATATE	104-31-4	BENZONATATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69336-126-15	69336012615	15 CAPSULE in 1 BOTTLE (69336-126-15)	15 capsule	2019-03-20	2022-04-25	No	No	Current